newsfilter
← Latest News
Business Wire·

Appili Therapeutics Reports Financial and Operational Results for Third Quarter of Fiscal Year 2023

Appili Therapeutics Inc. (TSX:APLI, OTCQB:APLIF) (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and biodefense, today announced its financial and operational